What CSR means for the world of health: An overview of CSR practices in the pharmaceutical industry

Nathalie Gimenes Marielle Audrey Payaud 1
1 Centre de Recherche Magellan
Abstract : This article proposes a new Corporate Social Responsibility (CSR) framework allowing the evaluation of responsible behaviors and practices in a specific industry. Considering the CSR as a negotiated order in ongoing construction, the partnership between the private and public parties can become a solution in the general interest. The implementation of these partnerships along the value chain enables CSR to be placed as a business opportunity that could develop the strategic potential of the company. The evaluation framework provides an objective view. We are going to mobilize this through an exploratory study filled with qualitative data obtained through websites and CSR reports from 2013 of the ten biggest multinational pharmaceutical industries, proving the know-how of this sector in the field of industrial durability.
Keywords : CSR evaluation framework exploratory study pharmaceutical industry
Document type :
Conference papers
Complete list of metadatas
https://hal-univ-lyon3.archives-ouvertes.fr/hal-01217939
Contributor : Nathalie Gimenes <>
Submitted on : Tuesday, October 20, 2015 - 1:27:51 PM
Last modification on : Wednesday, January 23, 2019 - 7:48:11 PM

Identifiers

  • HAL Id : hal-01217939, version 1

Collections

UNIV-LYON3 | MAGELLAN

Citation

Nathalie Gimenes, Marielle Audrey Payaud. What CSR means for the world of health: An overview of CSR practices in the pharmaceutical industry. 4th International Conference on Social Responsibility, Ethics and Sustainable Business, Georgiana Grigore, Oct 2015, athens, Greece. ⟨hal-01217939⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

113

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD